Delivery Order 75F40120D00032-75F40125F19011
Award Date 9/16/25
Potential Completion Date 9/16/26
Potential Value $300K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Takoma Park, MD 20901, USA
Solicitation Procedures
Two Step
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Food and Drug Administration has awarded a $75,000 firm fixed-price delivery order to We Pharma, Inc. (doing business as WEP Clinical) for the supply of pharmaceutical drug products. This non-set-aside contract, effective through November 13, 2026, represents a discrete task order under one of the company's existing Indefinite Delivery Indefinite Quantity (IDIQ) contracts with the FDA. Performance will take place in Silver Spring, Maryland, where the FDA maintains significant research and...
- The Department of Health and Human Services Food and Drug Administration (HHS FDA) awarded a firm fixed price delivery order contract to We Pharma, Inc. doing business as WEP Clinical, a self-certified small disadvantaged business, for the delivery of pharmaceutical drug products. The $182,616.74 award is in support of the FDA's research, regulatory compliance, and emergency response operations, and represents task orders under a larger 5-year, $6 million indefinite delivery contract awarded...
- This is a delivery order awarded by the Food and Drug Administration (FDA) to We Pharma, Inc., a self-certified small disadvantaged business structured as a limited liability company. The contract, valued at $357,000.00, is for the provision of pharmaceutical drug products to support the FDA's various research, regulatory, and emergency response activities. We Pharma, doing business as WEP Clinical, holds two significant Indefinite Delivery Contracts (IDCs) with the FDA, totaling $9.5 million...
- This delivery order, awarded by the Department of Health and Human Services' Food and Drug Administration, is for $240,000 worth of pharmaceutical products to support domestic manufacturing and regulatory purposes. We Pharma, Inc. will provide the products in Takoma Park, Maryland by September 30, 2023 under a firm fixed price arrangement. As the FDA works to ensure the safety and effectiveness of drugs and medical devices, this contract will help the agency assess pharmaceutical manufacturing...
- This firm-fixed-price purchase order was awarded by the Food and Drug Administration (FDA), a civilian agency under the Department of Health and Human Services, to We Pharma, Inc., a self-certified small disadvantaged business. The $214,914.90 contract is for the provision of "PHYSICOCHEMICAL PRODUCTS" and has a total small business set-aside. The award supports the FDA's regulatory science program and provides pharmaceutical drug products for the agency's research, compliance, and...
- This delivery order against the Department of Health and Human Services Food and Drug Administration is for the purpose of obtaining currently marketed drug products for FDA research studies. Awarded on September 30, 2020 to We Pharma, Inc. located in Morrisville, North Carolina, this firm fixed price contract has a potential value of $246,754.22 and period of performance through September 29, 2021. No set-aside designation was applied. We Pharma Inc. will provide the requested drug products...
- The U.S. Food and Drug Administration (FDA) awarded a $200,000 delivery order contract to Realm Research LLC, a minority-owned small disadvantaged woman-owned small business, to monitor the conduct and progress of extramural FDA-funded research studies in human subjects overseen by the Center for Drug Evaluation and Research (CDER). This contract is part of a larger $1.1 million indefinite delivery contract awarded to Realm Research in 2023 to provide broader scientific and clinical support...
- The Food and Drug Administration (FDA) awarded a $4,709,471.91 delivery order contract to Priority One Services, Inc., a minority-owned and self-certified small disadvantaged business. The contract is for veterinary technical support and animal care and vivarium management services for the FDA's White Oak Animal Program (WOAP) located in Silver Spring, Maryland. This contract is a task order under Priority One Services' existing $25 million indefinite-delivery, indefinite-quantity (IDIQ)...
- The Food and Drug Administration (FDA) has awarded a delivery order contract to Computer Evidence Specialists, LLC (CES), a minority-owned, service-disabled veteran-owned small business, to obtain 600 UBS, 300 A & L's, 2,268 program management hours, non-inspection travel, and other direct costs to complete inspections in Washington, DC. This task order has a total ceiling value of $226,709.04 and is a firm fixed price contract. Additionally, the FDA has issued an administrative modification...
- The Department of Health and Human Services Food and Drug Administration (FDA) awarded a Firm Fixed Price, Definitive Contract to Userwise, LLC, a self-certified Small Disadvantaged Business, Woman-Owned Small Business, and Limited Liability Company. The $461,491.88 contract is for a project titled "Training Decay Selection for Medical Product Usability Validation Testing." The contract was awarded on September 12, 2018 with a completion date of December 18, 2022. The original...